X-Change Corp. Quickly Advances to Testing Stage with Its 'Phytiva'
Brand of Products
DALLAS, Jan. 31, 2013 /PRNewswire/ -- X-Change
Corporation (NASDAQ OTC: XCHC), a U.S. publicly-traded company,
through its European joint venture with Dupetit Natural Products,
GmbH, announces that within one week the Company will move into the
testing stage of development of its unique hemp-based Phytiva brand
of products, as the Company prepares to bring these products to
European and North American markets.
The first testers of these Phytiva Brand products are ready for
production and packaging and will include anti-aging skin care and
rejuvenation products, including hemp-based lip balms, supplements,
moisturizers, and sunscreen. After testing these products, the
Company will aggressively market them for over-the-counter (OTC)
sales targeting a wide range of cosmetic and ailment-related
usages.
"The Company is moving even more quickly than anticipated in
creating testers for its initial hemp-based Phytiva Brand products;
therefore, we are excited to announce that these cutting-edge
products will be brought to market sooner than expected," said
Chad S. Johnson, Esq., Chief
Operating Officer of X-Change Corporation.
About X-Change Corp.
X-Change Corp. has acquired both the Phytiva Brand of products
and all associated rights and Companies and the European JV with
Dupetit from Cannabis Science, Inc. The Phytiva products acquired
by X-Change Corp. are unique hemp-inclusive products for skin care
and rejuvenation. These are the first products of the company
to be released publicly. These initial products include lip
balms, extracts, supplements, and dermal creams, targeting a wide
range of cosmetic and ailment-related usages.
Forward Looking Statements
This Press Release includes forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Act of 1934. A statement containing
works such as "anticipate," "seek," intend," "believe," "plan,"
"estimate," "expect," "project," "plan," or similar phrases may be
deemed "forward-looking statements" within the meaning of the
Private Securities Litigation Reform Act of 1995. Some or all of
the events or results anticipated by these forward-looking
statements may not occur. Factors that could cause or contribute to
such differences include the future U.S. and global economies, the
impact of competition, and the Company's reliance on existing
regulations regarding the use and development of cannabis-based
drugs. X-Change Corp. does not undertake any duty nor does it
intend to update the results of these forward-looking
statements.
|
X-Change
Corp.
President
& CEO
Robert
Kane
info@phytiva.com
www.phytiva.com
|
SOURCE X-Change Corp.